Status:
UNKNOWN
Comparing Ropivacaine Adductor Canal Blockade by Surgeon Versus Anesthesiologist
Lead Sponsor:
Rothman Institute Orthopaedics
Collaborating Sponsors:
Sharpe-Strumia Research Foundation
Conditions:
Pain, Postoperative
Satisfaction
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the efficacy of two methods of administering an adductor canal block (ACB) following total knee arthroplasty (TKA); intraoperative surgeon performed intra-arti...
Eligibility Criteria
Inclusion
- Patients undergoing unilateral primary TKA with underlying diagnosis of osteoarthritis
- ASA I - III
- Spinal anesthesia
- All patients will have cemented total knee utilizing a medial parapatellar approach with posterior stabilized or cruciate retaining implants. A tourniquet will be used in all cases.
- Patients must be between 18 and 80 years of age.
- Active and valid email address for the participant.
Exclusion
- Allergy to anesthetics or study analgesic medications.
- Contraindication to regional anesthesia
- Non-english speaking
- ASA IV or greater
- Renal insufficiency with Cr \> 2.0 or hepatic failure
- General or epidural anesthesia
- Sensory/motor disorder involving the operative limb
- Patients who consume preoperative opioids for pain control.
- Pregnant women
- Mentally disabled patients and patients with psychiatric disorders that would prevent them from properly understanding and evaluating an informed consent process.
- Prisoners
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2019
Estimated Enrollment :
164 Patients enrolled
Trial Details
Trial ID
NCT03864588
Start Date
October 1 2018
End Date
September 1 2019
Last Update
March 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rothman Institute
Philadelphia, Pennsylvania, United States, 19107